Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
amivantamab epidermal growth factor receptor biotech Successful target TTD , drugbank Insertion Mutation[MeSHID:D016254]
Disease[MeSHID:D004194]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational,phase 3 antibody,downregulator
amivantamab low affinity immunoglobulin gamma fc region receptor iii-a biotech NA drugbank Insertion Mutation[MeSHID:D016254]
Disease[MeSHID:D004194]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational inducer
amivantamab proto-oncogene c-met NA Successful target TTD Insertion Mutation[MeSHID:D016254]
Disease[MeSHID:D004194]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA phase 3 unknown
amivantamab hepatocyte growth factor receptor biotech NA drugbank Insertion Mutation[MeSHID:D016254]
Disease[MeSHID:D004194]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational antagonist,antibody
click here to return to the previous page